129 related articles for article (PubMed ID: 10098152)
1. [Hexosaminidase deficiency as differential spinocerebellar diseases].
Förster A; Heuss D; Claus D
Nervenarzt; 1999 Feb; 70(2):162-6. PubMed ID: 10098152
[TBL] [Abstract][Full Text] [Related]
2. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings.
Hund E; Grau A; Fogel W; Forsting M; Cantz M; Kustermann-Kuhn B; Harzer K; Navon R; Goebel HH; Meinck HM
J Neurol Sci; 1997 Jan; 145(1):25-31. PubMed ID: 9073025
[TBL] [Abstract][Full Text] [Related]
3. GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
Federico A
Adv Exp Med Biol; 1987; 209():19-23. PubMed ID: 2953177
[No Abstract] [Full Text] [Related]
4. Discovery of beta-hexosaminidase A deficiency in Tay-Sachs disease.
Okada S; O'Brien JS
Adv Genet; 2001; 44():61-6. PubMed ID: 11596999
[No Abstract] [Full Text] [Related]
5. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
6. Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease.
Cohen-Tannoudji M; Marchand P; Akli S; Sheardown SA; Puech JP; Kress C; Gressens P; Nassogne MC; Beccari T; Muggleton-Harris AL
Mamm Genome; 1995 Dec; 6(12):844-9. PubMed ID: 8747922
[TBL] [Abstract][Full Text] [Related]
7. Tay-Sachs disease screening and diagnosis: evolving technologies.
Hechtman P; Kaplan F
DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
[TBL] [Abstract][Full Text] [Related]
8. Hexosaminidase A deficiency presenting as juvenile progressive dystonia.
Hardie RJ; Young EP; Morgan-Hughes JA
J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):446-7. PubMed ID: 2966237
[No Abstract] [Full Text] [Related]
9. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.
Yamanaka S; Johnson MD; Grinberg A; Westphal H; Crawley JN; Taniike M; Suzuki K; Proia RL
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9975-9. PubMed ID: 7937929
[TBL] [Abstract][Full Text] [Related]
11. Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review.
Adams C; Green S
Dev Med Child Neurol; 1986 Apr; 28(2):236-43. PubMed ID: 2940136
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
[TBL] [Abstract][Full Text] [Related]
13. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.
Felderhoff-Mueser U; Sperner J; Konstanzcak P; Navon R; Weschke B
J Child Neurol; 2001 May; 16(5):377-80. PubMed ID: 11392526
[TBL] [Abstract][Full Text] [Related]
14. [Tay-Sachs disease (beta-hexosaminidase alpha-chain deficiency)].
Okada S; Taniike M
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):394-6. PubMed ID: 9645090
[No Abstract] [Full Text] [Related]
15. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
[No Abstract] [Full Text] [Related]
16. [Spinal muscular atrophy: a hexosaminidase A deficiency phenotype].
Kawanami T; Kato T
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):379-81. PubMed ID: 10434678
[No Abstract] [Full Text] [Related]
17. Hexosaminidase--pseudodeficiency?
Kappler J; Gieselmann V; Propping P
Am J Hum Genet; 1990 Nov; 47(5):880-2. PubMed ID: 2145759
[No Abstract] [Full Text] [Related]
18. Tay-Sachs disease: B1 variant.
Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of hexosaminidase A deficiency and pseudodeficiency in the Berks County Pennsylvania Dutch.
Mules EH; Hayflick S; Dowling CE; Kelly TE; Akerman BR; Gravel RA; Thomas GH
Hum Mutat; 1992; 1(4):298-302. PubMed ID: 1301937
[TBL] [Abstract][Full Text] [Related]
20. [Tay-Sachs disease: a case report].
Koch S; Widhalm K
Padiatr Padol; 1991; 26(6):275-8. PubMed ID: 1838805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
